Related Experiment Video

Updated: Jan 10, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.6K

Stromal Defense Against Cancer: An Unprecedented Mechanism Limiting Cancer Invasion Into the Bone

Masayuki Tsukasaki1,2, Hiroshi Takayanagi3

  • 1Department of Biochemistry, Showa Medical University School of Dentistry, Tokyo, Japan.

Cancer Science
|November 23, 2025
PubMed

Insights

The bone

Area of Science:

  • Oncology
  • Immunology
  • Bone Biology

Background:

  • Immune checkpoint inhibitors have transformed cancer treatment.
  • Non-immune system roles in tumor regulation are understudied.
  • Cancer bone invasion presents a significant clinical challenge.

Purpose of the Study:

  • To introduce the concept of stromal defense against cancer (SDAC).
  • To elucidate the mechanisms by which stromal cells impede cancer bone invasion.
  • To explore the clinical implications of SDAC in oncology.

Main Methods:

  • Investigated host defense mechanisms against cancer bone invasion.
  • Focused on the periosteum's response to tumor proximity.
  • Characterized the molecular and cellular activities of stromal cells.

Main Results:

  • Discovered a novel host defense mechanism involving periosteal stromal cells.
  • Periosteal stromal cells actively thicken the tissue to block tumor invasion.
  • Proposed the "stromal defense against cancer (SDAC)" as a new regulatory mechanism.

Conclusions:

  • SDAC represents a significant, previously unrecognized host defense against cancer.
  • Stromal cell activity in the periosteum physically impedes bone invasion.
  • Understanding SDAC offers new therapeutic strategies for bone metastases.
Keywords:
SDACbonehead and neck squamous cell carcinomaperiosteumstromal cells

More Related Videos

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting05:34

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting

Published on: November 20, 2015

33.7K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.4K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K